Mikhail Blagosklonny’s contributions to medical science
Mikhail Blagosklonny is a Russian scientists who studies aging and cancer. He works as at the Roswell Park Cancer institute in New york City, USA as Professor of oncology. Mikhail Blagosklonny went to the First Pavlov State Medical University of St. Peterburg from which he earned his M. D. in internal medicine and Ph. D. in experimental medicine and cardiology.
In 2002 he was promoted to the position of associate professor of medicine at the New York Medical College, Valhalla, NY. After that he got a position at Ordway Research Institute located in Albany, New York as a senior scientist. In 2009 he moved on from that position to serve as a professor of oncology and teach at the Roswell Park Cancer Institute. Mikhail Blagosklonny’s does research in the field of cancer. He studies targeted cancer therapies that protect healthy cells from being damaged as well as how aging works or the science of biogerontology as well as different drugs meant to slow down the process of aging. Mikhail Blagosklonny developed a hypothesis about the probable part that TOR signaling plays in the process of not only aging but the development of cancer cells as well. Mikhail Blagosklonny also suggested the use of a widely known drug against cancer – repamycin. His reason for that is that the repamycin drug may be able to extend the life expectation of a person. Mikhail Blagosklonny has acquired the reputation of one of the most avid supporters of rapamycin as a tool to extend the longevity of a person. View Mikhail’s profile on Google Scholar
Mikhail Blagosklonny also takes interest in editorial writing. He is chief editor of a few medical magazines such as Cell Cycle, Aging and Oncotarget. Mikhail Blagosklonny is associate editor for the magazine Cancer Biology and Therapy. Other editorial writings that Mikhail Blagosklonny has done are his published papers that nearly reach the number 300. He has also given a number of speeches on the matters of cancer and aging and has become a source of inspiration for many medical students all over the world. His contribution to medicine has made him known on international levels. Read more about Mikhail at LinkedIn.com